The oncogene heregulin induces apoptosis in breast epithelial cells and tumors - PubMed (original) (raw)
. 1998 Oct 22;17(16):2107-13.
doi: 10.1038/sj.onc.1202428.
Affiliations
- PMID: 9798682
- DOI: 10.1038/sj.onc.1202428
The oncogene heregulin induces apoptosis in breast epithelial cells and tumors
E J Weinstein et al. Oncogene. 1998.
Abstract
The products of a growing number of genes have been shown to display seemingly contradictory functions; namely, the induction of tumorigenesis and the induction of apoptosis. Heregulin's involvement in oncogenesis occurs through its interactions with members of the EGF receptor tyrosine kinase family. Recently one isoform of heregulin, beta2b, was isolated in an in vitro screen for dominant, apoptosis-inducing genes in kidney epithelial cells. Here we show that heregulin is also capable of mediating apoptosis in human and murine mammary tumor cell lines and murine tumors. Furthermore, through transfection of the human breast cancer cell line MCF-7 with the truncated transmembrane/cytoplasmic segment of the heregulin gene, we show that the intracellular region of the heregulin precursor is sufficient for induction of apoptosis. Through the use of DNA fragmentation assays we also show that apoptosis occurs in cell lines established from heregulin-induced mammary gland tumors. TdT addition of digoxigenin labeled nucleotides to 3' OH ends of DNA breaks recapitulated these results in the actual tumors. Finally, over-expression of heregulin is shown to lead to the down-regulation of Bcl-2, an inhibitor of apoptosis. Conversely, the transfection of Bcl-2 into MCF-7 cells inhibits heregulin-mediated programmed cell death.
Similar articles
- Normal breast epithelial cells induce apoptosis of MCF-7 breast cancer cells through a p53-mediated pathway.
Toillon RA, Adriaenssens E, Wouters D, Lottin S, Boilly B, Hondermarck H, Bourhis XL. Toillon RA, et al. Mol Cell Biol Res Commun. 2000 Jun;3(6):338-44. doi: 10.1006/mcbr.2000.0236. Mol Cell Biol Res Commun. 2000. PMID: 11032755 - Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53.
Mathiasen IS, Lademann U, Jäättelä M. Mathiasen IS, et al. Cancer Res. 1999 Oct 1;59(19):4848-56. Cancer Res. 1999. PMID: 10519395 - Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of p53 phosphorylation and reactive oxygen species generation.
Chen T, Wong YS. Chen T, et al. Int J Biochem Cell Biol. 2009 Mar;41(3):666-76. doi: 10.1016/j.biocel.2008.07.014. Epub 2008 Aug 5. Int J Biochem Cell Biol. 2009. PMID: 18718551 - The significance of heregulin in breast cancer tumor progression and drug resistance.
Lupu R, Cardillo M, Cho C, Harris L, Hijazi M, Perez C, Rosenberg K, Yang D, Tang C. Lupu R, et al. Breast Cancer Res Treat. 1996;38(1):57-66. doi: 10.1007/BF01803784. Breast Cancer Res Treat. 1996. PMID: 8825123 Review.
Cited by
- Epigenetic regulation of Neuregulin 1 promotes breast cancer progression associated to hyperglycemia.
Lee C, Kim M, Park C, Jo W, Seo JK, Kim S, Oh J, Kim CS, Ryu HS, Lee KH, Park J. Lee C, et al. Nat Commun. 2023 Jan 27;14(1):439. doi: 10.1038/s41467-023-36179-8. Nat Commun. 2023. PMID: 36707514 Free PMC article. - NRG1 Genetic Variant Influences the Efficacy of Androgen-Deprivation Therapy in Men with Prostate Cancer.
Huang SP, Chen YT, Chen LC, Lee CH, Huang CY, Yu CC, Lin VC, Lu TL, Bao BY. Huang SP, et al. Biomedicines. 2021 May 10;9(5):528. doi: 10.3390/biomedicines9050528. Biomedicines. 2021. PMID: 34068503 Free PMC article. - NRG1 fusions in breast cancer.
Howarth KD, Mirza T, Cooke SL, Chin SF, Pole JC, Turro E, Eldridge MD, Garcia RM, Rueda OM, Boursnell C, Abraham JE, Caldas C, Edwards PAW. Howarth KD, et al. Breast Cancer Res. 2021 Jan 7;23(1):3. doi: 10.1186/s13058-020-01377-5. Breast Cancer Res. 2021. PMID: 33413557 Free PMC article. - Neuregulin1 acts as a suppressor in human lung adenocarcinoma via AKT and ERK1/2 pathway.
Wang Y, Ning Z, Zhou X, Yang Z, Tang H, Xu M, Wang X, Zhao J, Bai Y. Wang Y, et al. J Thorac Dis. 2018 Jun;10(6):3166-3179. doi: 10.21037/jtd.2018.05.175. J Thorac Dis. 2018. PMID: 30069312 Free PMC article. - Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancer.
Moelans CB, van Maldegem CMG, van der Wall E, van Diest PJ. Moelans CB, et al. Oncotarget. 2018 Mar 30;9(24):17078-17092. doi: 10.18632/oncotarget.24904. eCollection 2018 Mar 30. Oncotarget. 2018. PMID: 29682206 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases